Skip to main content
. Author manuscript; available in PMC: 2014 Mar 14.
Published in final edited form as: JACC Cardiovasc Imaging. 2012 Sep;5(9):897–907. doi: 10.1016/j.jcmg.2012.04.006

Table 1.

Indications for CMR and Final Diagnosis After Complete Clinical Evaluation in 38 Patients

Indication for Referral to CMR

Final Diagnosis Known CA Unexplained
Thickened LV or
ECG Voltage
Criteria for LVH
Systemic
Infiltrative
Disease
Total
CA
  By biopsy 7 7 0 14 (37%)
  By clinical diagnosis 1 1 1 3 (8%)

Non-amyloid CMP 0 18 2 20 (53%)

Lysosomal storage disease 0 0 1 1 (5%)

Total 8 (17%) 26 (55%) 4 (9%) 38

CA = cardiac amyloidosis; CMP = cardiomyopathy; CMR = cardiac magnetic resonance imaging; ECG = electrocardiogram; LVH = left ventricular hypertrophy; LV = left ventricular.